Select Publications

Books

Epstein R, 2025, Cancer - The Inside Story, Turner J, (ed.), Power Writers Publishing Group, Sydney, https://www.amazon.com.au/CANCER-INSIDE-STORY-Meet-Treat-ebook/dp/B0FH476Y3S/ref=sr_1_1?crid=37HJE2ZOLJYH4&dib=eyJ2IjoiMSJ9.2VKu72U2CIF64PV3ggedPxj8ofdJ7RkcsEZ5BKBr-po.3k-PRwr4LT44fpiKrCo49RtBoI0lyzjqWUFD7_jc9ow&dib_tag=se&keywords=epstein+cancer+inside+story&qid=1794053131&sprefix=epstein+cancer+inside+story%2Caps%2C220&sr=8-1#detailBullets_feature_div

Epstein RJ, 2003, Human Molecular Biology An Introduction to the Molecular Basis of Health and Disease, Cambridge University Press

Epstein R, 2003, medicine for examinations

Book Chapters

Epstein RJ; Todd D, 2006, 'Professionalism', in Problem Based Medical Case Management, pp. 271 - 279

Epstein R, 2004, 'Pathogenesis of Cancer', in A Clinical Approach to Medicine, World Scientific Publishing, pp. 869 - 874, http://dx.doi.org/10.1142/9789812565822_0050

EPSTEIN RJ, 2001, 'Pathogenesis of Cancer', in A Clinical Approach to Medicine, World Scientific Publishing, pp. 567 - 572, http://dx.doi.org/10.1142/9789810248178_0029

Epstein RJ; Henderson IC, 1993, 'Chemotherapy for Node-Negative Breast Cancer', in Non-Disseminated Breast Cancer, Springer Nature, pp. 43 - 56, http://dx.doi.org/10.1007/978-3-642-84593-2_6

Journal articles

Francis PA; Pagani O; Fleming GF; Walley B; Colleoni M; Rubovszky G; Tondini C; Ciruelos EM; Gomez HL; Bonnefoi HR; Burstein HJ; Chini C; Puglisi F; Spazzapan S; Bernardo A; Climent MA; Bellet M; Ruhstaller T; Bermejo B; Chia SKL; Martino S; Geyer CE; Goetz MP; Ingle JN; Stearns V; Davidson NE; Le Du F; Müller B; Coleman RE; Loibl S; Winer EP; Ruepp B; Loi S; Láng I; Coates AS; Gelber RD; Goldhirsch A; Regan MM; Colleoni M; Loi S; Hiltbrunner A; Allemann S; Gasca A; Kammler R; Maibach R; Rabaglio-Poretti M; Roschitzki H; Roux S; Schroeder J; Regan M; Bouzan C; Gelber R; Giobbie-Hurder A; Huang H; Price K; Shaw H; Blacher L; Blackwell M; Greco M; Mora de Karausch A; Narayanan D; Polizzi D; Scott K; Starkweather R; Viale G; Arrigoni L; Benini E; Dell’Orto P; Russo L; Bernhard J; Ribi K; Piccart-Gebhart M; Cameron D; El-Abed S; Abrams J; Korde L; Mooney M; Zujewski JA; Winer E; Savoie J; Francis P; Fleming G; Pagani O; Regan M; Bonnefoi L; Colleoni M; De Meulemeester L; Ciruelos E; Coates A; El-Abed S; Gelber R; Hiltbrunner A; Roschitzki-Voser H; Kammler R; Loi S; Loibl S; Shaw H; Koczwara B; Epstein R, 2026, 'Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer☆', Annals of Oncology, 37, pp. 1367 - 1385, http://dx.doi.org/10.1016/j.annonc.2026.05.704

Tan E; Epstein R; Ahmed S; Williams HC, 2026, 'Paper mills in dermatology: a cross-sectional study of retracted publications', British Journal of Dermatology, pp. ljag381, http://dx.doi.org/10.1093/bjd/ljag381

Tan E; Lim S; Lamont D; Epstein R; Lim D; Lin FPY, 2024, 'Development and validation of a deep learning model for improving detection of nonmelanoma skin cancers treated with Mohs micrographic surgery', Jaad International, 14, pp. 39 - 47, http://dx.doi.org/10.1016/j.jdin.2023.10.007

Lin FP-Y; Joshua AM; Epstein RJ, 2023, 'Machine learning prediction of patient-reported outcomes associated with systemic therapy from medical records.', Journal of Clinical Oncology, 41, pp. e13564 - e13564, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e13564

Tempero MA; Pelzer U; O'Reilly EM; Winter J; Oh DY; Li CP; Tortora G; Chang HM; Lopez CD; Bekaii-Saab T; Ko AH; Santoro A; Park JO; Noel MS; Frassineti GL; Shan YS; Dean A; Riess H; Van Cutsem E; Berlin J; Philip P; Moore M; Goldstein D; Tabernero J; Li M; Ferrara S; Le Bruchec Y; Zhang G; Lu B; Biankin AV; Reni M; Epstein R; Vasey P; Shapiro J; Burge M; Chua YJ; Harris M; Pavlakis N; Tebbutt N; Prager G; Dittrich C; Längle F; Philipp-Abbrederis K; Greil R; Stöger H; Girschikofsky M; Kuehr T; Van Laethem JL; Laurent S; Dhani N; Ko YJ; Dowden S; Kavan P; Tehfe M; Kubala E; Kohoutek M; Pfeiffer P; Yilmaz M; Parner V; Salminen T; Soveri LM; Korkeila E; Osterlund P; Taieb J; Tougeron D; Artru P; Caroli-Bosc FX; Guimbaud R; Turpin A; Walter T; Bachet JB; Kunzmann V; Kreth F; Block A; Venerito M; Oettle H; Karthaus M; Trojan J; Folprecht G; Lerch M; Kullmann F; Reiser M; Heinemann V; Wörns MA; Schulz H; Garlipp B; Yau T; Chan LS; Juhasz B; Landherr L; Pinter T; Bodoky G; Kahán Z; McDermott R; Power D; Gianni L; Siena S; Milella M; Falcone A; Berardi R, 2023, 'Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results from a Randomized, Open-Label, Phase III Trial', Journal of Clinical Oncology, 41, pp. 2007 - 2019, http://dx.doi.org/10.1200/JCO.22.01134

Epstein RJ; Lin FPY; Brink RA; Blackburn J, 2023, 'Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice', Plos One, 18, pp. e0284327, http://dx.doi.org/10.1371/journal.pone.0284327

Epstein RJ; Gu Y; Lin FPY, 2023, 'Can cancer go green? It’s up to us', Frontiers in Oncology, 13, pp. 1074091, http://dx.doi.org/10.3389/fonc.2023.1074091

Epstein RJ, 2023, 'To find fault is easy, to find no-fault is fair', Future Healthcare Journal, 10, pp. 85 - 89, http://dx.doi.org/10.7861/fhj.2022-0049

Po-Yen Lin F; Salih OSM; Scott N; Jameson MB; Epstein RJ; Lin F, 2022, 'Development and Validation of a Machine Learning Approach Leveraging Real-World Clinical Narratives as a Predictor of Survival in Advanced Cancer', JCO Clinical Cancer Informatics, 6, pp. e2200064, http://dx.doi.org/10.1200/CCI.22.00064

Epstein RJ, 2021, 'The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor', Tumor Biology, 43, pp. 159 - 176, http://dx.doi.org/10.3233/TUB-211502

Epstein RJ; Tian LJ; Gu YF, 2021, '2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology', Journal of Oncology, 2021, pp. 9955456, http://dx.doi.org/10.1155/2021/9955456

Gu YF; Lin FP; Epstein RJ, 2021, 'How aging of the global population is changing oncology', Ecancermedicalscience, 15, pp. ed119, http://dx.doi.org/10.3332/ecancer.2021.ed119

Lami H; Epstein RJ; Cherepanoff S; Conway RM, 2020, 'Effective conservative management of locally advanced conjunctival melanoma using initial systemic therapy', Clinical and Experimental Ophthalmology, 48, pp. 402 - 404, http://dx.doi.org/10.1111/ceo.13691

Sternberg CN; Saad F; Graff JN; Peer A; Vaishampayan UN; Leung E; Rosenbaum E; Gurney H; Epstein RJ; Davis ID; Wu B; Trandafir L; Wagner VJ; Hussain M, 2020, 'A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer', Annals of Oncology, 31, pp. 257 - 265, http://dx.doi.org/10.1016/j.annonc.2019.10.025

Vasista A; Stockler M; Martin A; Pavlakis N; Sjoquist K; Goldstein D; Gill S; Jain V; Liu G; Kannourakis G; Kim YH; Nott L; Snow S; Burge M; Harris D; Jonker D; Chua YJ; Epstein R; Bonaventura A; Kiely B, 2019, 'Accuracy and Prognostic Significance of Oncologists’ Estimates and Scenarios for Survival Time in Advanced Gastric Cancer', Oncologist, 24, pp. e1102 - e1107, http://dx.doi.org/10.1634/theoncologist.2018-0613

Lin FP-Y; Jameson MB; Epstein RJ, 2019, 'Predicting survival in advanced cancers by applying machine learning to clinical narratives.', Journal of Global Oncology, 5, pp. 32 - 32, http://dx.doi.org/10.1200/jgo.2019.5.suppl.32

Young FP; Ende D; Epstein RJ, 2019, 'Beyond BCG: The approaching era of personalised bladder-sparing therapies for non-muscle-invasive urothelial cancers', Future Oncology, 15, pp. 409 - 420, http://dx.doi.org/10.2217/fon-2018-0565

Emmett L; Crumbaker M; Ho B; Willowson K; Eu P; Ratnayake L; Epstein R; Blanksby A; Horvath L; Guminski A; Mahon K; Gedye C; Yin C; Stricker P; Joshua AM, 2019, 'Results of a Prospective Phase 2 Pilot Trial of 177 Lu–PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression', Clinical Genitourinary Cancer, 17, pp. 15 - 22, http://dx.doi.org/10.1016/j.clgc.2018.09.014

Emmett L; Yin C; Crumbaker M; Hruby G; Kneebone A; Epstein R; Nguyen Q; Hickey A; Ihsheish N; O'Neill G; Horvath L; Chalasani V; Stricker P; Joshua AM, 2019, 'Rapid modulation of PSMA expression by androgen deprivation: Serial 68Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen blockade', Journal of Nuclear Medicine, 60, pp. 950 - 954, http://dx.doi.org/10.2967/jnumed.118.223099

Francis PA; Pagani O; Fleming GF; Walley BA; Colleoni M; Láng I; Gómez HL; Tondini C; Ciruelos E; Burstein HJ; Bonnefoi HR; Bellet M; Martino S; Geyer CE; Goetz MP; Stearns V; Pinotti G; Puglisi F; Spazzapan S; Climent MA; Pavesi L; Ruhstaller T; Davidson NE; Coleman R; Debled M; Buchholz S; Ingle JN; Winer EP; Maibach R; Rabaglio-Poretti M; Ruepp B; Di Leo A; Coates AS; Gelber RD; Goldhirsch A; Regan MM, 2018, 'Tailoring adjuvant endocrine therapy for premenopausal breast cancer', New England Journal of Medicine, 379, pp. 122 - 137, http://dx.doi.org/10.1056/NEJMoa1803164

Smith MR; Saad F; Chowdhury S; Oudard S; Hadaschik BA; Graff JN; Olmos D; Mainwaring PN; Lee JY; Uemura H; Lopez-Gitlitz A; Trudel GC; Espina BM; Shu Y; Park YC; Rackoff WR; Yu MK; Small EJ, 2018, 'Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer', New England Journal of Medicine, 378, pp. 1408 - 1418, http://dx.doi.org/10.1056/nejmoa1715546

Lin FP; Epstein RJ; Groza T; Kocbek S; Antezana E, 2018, 'Cancer care treatment outcome ontology: A novel computable ontology for profiling treatment outcomes in patients with solid tumors', JCO Clinical Cancer Informatics, 2018, pp. 1 - 14, http://dx.doi.org/10.1200/CCI.18.00026

Lin FPY; Pokorny A; Teng C; Epstein RJ, 2017, 'TEPAPA: A novel in silico feature learning pipeline for mining prognostic and associative factors from text-based electronic medical records', Scientific Reports, 7, pp. 6918, http://dx.doi.org/10.1038/s41598-017-07111-0

Fazekas-Lavu M; Parker A; Spigelman AD; Scott RJ; Epstein RJ; Jensen M; Samaras K, 2017, 'Thyroid cancer in a patient with lynch syndrome – case report and literature review', Therapeutics and Clinical Risk Management, 13, pp. 915 - 918, http://dx.doi.org/10.2147/TCRM.S121812

Epstein RJ; Lin FP, 2017, 'Cancer and the omics revolution', Australian Family Physician, 46, pp. 189 - 193

Vasista A; Martin A; Pavlakis N; Sjoquist K; Snow S; Jonker D; Chua YJ; Epstein R; Bonaventura A; Khasraw M; Varma SC; Singhal N; Ransom DT; Aubin F; Burkes R; Lim H; Lemay F; Begbie S; Stockler MR; Kiely B, 2017, '666P Accuracy and prognostic significance of oncologists’ estimates and scenarios for survival time in a randomised Phase 2 trial of regorafenib in advanced gastric cancer', Annals of Oncology, 28, pp. v226 - v227, http://dx.doi.org/10.1093/annonc/mdx369.050

Epstein RJ, 2016, 'Be careful what you wish for', Medical Journal of Australia, 205, pp. 521 - 522.e1, http://dx.doi.org/10.5694/MJA16.00836

Lin FPY; Pokorny A; Teng C; Dear R; Epstein RJ, 2016, 'Computational prediction of multidisciplinary team decision-making for adjuvant breast cancer drug therapies: A machine learning approach', BMC Cancer, 16, pp. 929, http://dx.doi.org/10.1186/s12885-016-2972-z

Blackburn J; Roden DL; Ng R; Wu J; Bosman A; Epstein RJ, 2016, 'Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter', Molecular Carcinogenesis, 55, pp. 1940 - 1951, http://dx.doi.org/10.1002/mc.22441

Borgman-Hagey A; Peltola K; Roth BJ; Maroto P; Scheffold C; Schwab GM; Escudier B; Powles T; Mainwaring PN; Rini BI; Donskov F; Hammers H; Hutson TE; Lee J-L; Bjarnason GA; Géczi L; Keam B; Heng DYC; Schmidinger M; Kantoff PW; Hessel C; Tannir NM; Motzer RJ; Choueiri TK, 2015, 'Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma', The New England Journal of Medicine, 373, pp. 1814 - 1823, http://dx.doi.org/10.1056/nejmoa1510016

Zheng S; Chan H; Epstein RJ; Joseph JE, 2015, 'Resolution of paraneoplastic immune thrombocytopenia following everolimus treatment for metastatic renal cell carcinoma', Internal Medicine Journal, 45, pp. 666 - 669, http://dx.doi.org/10.1111/imj.12779

Epstein RJ, 2015, 'A periodic table for cancer', Future Oncology, 11, pp. 785 - 800, http://dx.doi.org/10.2217/fon.14.315

Epstein RJ, 2015, '“By the way doctor, I’ve booked an African safari after my next chemo”', The BMJ, 350, pp. g7822, http://dx.doi.org/10.1136/bmj.g7822

Francis PA; Regan MM; Fleming GF; Láng I; Ciruelos E; Bellet M; Bonnefoi HR; Climent MA; Da Prada GA; Burstein HJ; Martino S; Davidson NE; Geyer CE; Walley BA; Coleman R; Kerbrat P; Buchholz S; Ingle JN; Winer EPM; Rabaglio-Poretti M; Maibach R; Ruepp B; Giobbie-Hurder A; Price KN; Colleoni M; Viale G; Coates AS; Goldhirsch A; Gelber RD, 2015, 'Adjuvant ovarian suppression in premenopausal breast cancer', New England Journal of Medicine, 372, pp. 436 - 446, http://dx.doi.org/10.1056/NEJMoa1412379

Ding P; Tai J; Manders P; Stone E; Ho B; Epstein R, 2015, '500P Dependence of fluorodeoxyglucose avidity on tumour size in non-small cell lung cancer', Annals of Oncology, 26, pp. ix153, http://dx.doi.org/10.1093/annonc/mdv534.04

Wong H; Lau S; Cheung P; Wong TT; Parker A; Yau T; Epstein RJ, 2014, 'Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: Implications for tumor biology and adjuvant therapy', BMC Cancer, 14, http://dx.doi.org/10.1186/1471-2407-14-826

Connolly K; Manders P; Earls P; Epstein RJ, 2014, 'Papillomavirus-associated squamous skin cancers following transplant immunosuppression: One Notch closer to control', Cancer Treatment Reviews, 40, pp. 205 - 214, http://dx.doi.org/10.1016/j.ctrv.2013.08.005

Pagani O; Regan MM; Walley BA; Fleming GF; Colleoni M; Láng I; Gomez HL; Tondini C; Burstein HJ; Perez EA; Ciruelos E; Stearns V; Bonnefoi HR; Martino S; Geyer CE; Pinotti G; Puglisi F; Crivellari D; Ruhstaller T; Winer EP; Rabaglio-Poretti M; Maibach R; Ruepp B; Giobbie-Hurder A; Price KN; Bernhard J; Luo W; Ribi K; Viale G; Coates AS; Gelber RD; Goldhirsch A; Francis PA, 2014, 'Adjuvant exemestane with ovarian suppression in premenopausal breast cancer', New England Journal of Medicine, 371, pp. 107 - 118, http://dx.doi.org/10.1056/NEJMoa1404037

Connolly K; Brungs D; Szeto E; Epstein RJ, 2014, 'Anticancer activity of combination targeted therapy using cetuximab plus vemurafenib for refractory BRAFV600E-mutant metastatic colorectal carcinoma', Current Oncology, 21, http://dx.doi.org/10.3747/co.21.1661

Quah XM; Conway RM; Madigan MC; Epstein RJ, 2014, 'Emerging strategies for therapeutic targeting of the tumour microenvironment', Cancer Forum, 38, pp. 133 - 137

Brungs D; Chen J; Masson P; Epstein RJ, 2014, 'Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: Results from a systematic review and meta-analysis', Prostate Cancer and Prostatic Diseases, 17, pp. 105 - 111, http://dx.doi.org/10.1038/pcan.2014.10

Zhang Q; Leung R; Wong H; Chiu J; Chu KW; Poon J; Epstein RJ; Kwong YL; Yau T, 2014, 'P9 Comparison of cetuximab and bevacizumab as first-line treatment in KRAS wild type advanced colorectal cancer patients: a retrospective analysis', European Journal of Cancer, 50, pp. s12, http://dx.doi.org/10.1016/s0959-8049(14)70040-1

Epstein RJ, 2013, 'The unpluggable in pursuit of the undruggable: Tackling the dark matter of the cancer therapeutics universe', Frontiers in Oncology, 3 DEC, http://dx.doi.org/10.3389/fonc.2013.00304


Back to profile page